Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0792
    -0.0001 (-0.01%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2636
    +0.0014 (+0.11%)
     
  • USD/JPY

    151.2170
    -0.1550 (-0.10%)
     
  • Bitcoin USD

    69,316.20
    -1,966.35 (-2.76%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,369.44
    +201.37 (+0.50%)
     

Celsius Holdings, Inc. to Present at the Goldman Sachs Global Staples Forum On May 16, 2023

BOCA RATON, Fla., May 12, 2023 /PRNewswire/ -- Celsius Holdings, Inc., (Nasdaq: CELH), maker of the leading global fitness drink, CELSIUS®, today announced the company will present at the Goldman Sachs Global Staples Forum on Tuesday, May 16, 2023.

Celsius Holdings, Inc. (PRNewsfoto/Celsius Holdings, Inc.)
Celsius Holdings, Inc. (PRNewsfoto/Celsius Holdings, Inc.)

Celsius CEO, John Fieldly, will be hosted by Goldman Sachs' beverage analyst Bonnie Herzog, for a fireside chat presentation at 11:00 a.m. ET, which will be webcast live.

Media and investors may access the live webcast at:
https://event.webcasts.com/starthere.jsp?ei=1612574&tp_key=626369c0c6&tp_special=8

The updated investor presentation incorporating Q1 2023 results, can be found at:
https://www.celsiusholdingsinc.com/investor-presentation

About Celsius Holdings, Inc.
Celsius Holdings, Inc. (Nasdaq: CELH), is a global consumer packaged goods company with a proprietary, clinically proven formula for its master brand CELSIUS®. A lifestyle energy drink born in fitness and a pioneer in the rapidly growing energy category. CELSIUS® offers proprietary, functional, essential energy formulas clinically-proven to offer significant health benefits to its users. CELSIUS® is backed by six university studies that were published in peer-reviewed journals validating the unique benefits CELSIUS® provides. For more information, please visit: http://www.celsiusholdingsinc.com

Investor Relations:
Cameron Donahue
(651) 707-3532
cdonahue@celsius.com
investorrelations@celsius.com

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/celsius-holdings-inc-to-present-at-the-goldman-sachs-global-staples-forum--on-may-16-2023-301823680.html

SOURCE Celsius Holdings, Inc.

Advertisement